The economic burden of preeclampsia: a systematic review.

In 30 seconds

This systematic review examined the economic burden of preeclampsia, synthesizing data from 12 studies primarily in high-income countries. The mean direct medical cost per patient was US$33,585.48, with significant national healthcare costs reported, including US$2.18 billion in the United States. The study underscores the financial impact of preterm birth as a key cost driver.

Key findings

• Mean direct medical costs for preeclampsia were US$33,585.48 per patient.
• National healthcare costs for preeclampsia were estimated at US$2.18 billion in the United States.
• Direct medical costs ranged from US$109.84 to US$87,339.71.
• Preterm birth significantly increases maternal and infant costs.

Why it matters

Understanding the economic burden of preeclampsia is crucial for healthcare policymakers and providers to allocate resources effectively and improve maternal and infant health outcomes.